SFI Health™ EMEA Announces the Launch in Portugal of Equazen® Food Supplements, the Brand Developed to Support Cognitive Needs
SFI Health™ EMEA, the regional entity of SFI Health™, a global leader in natural healthcare, is excited to announce that Equazen® products will soon be available in Portugal. The company specializes in clinically researched products in microbiome, cognition, and well-being.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250226258206/en/
Discover Equazen®, a science-based food supplement designed and studied to help nourish, enhance, and support the human brain’s potential across all life stages. (Graphic: Business Wire)
This marks a significant step forward in SFI Health™ EMEA's ongoing European expansion, following the exclusive license-in agreement signed in February 2024 with Eqyon Healthcare Solutions, a local distributor specialized in healthcare products. Under the terms of the agreement, Eqyon will use its sales and marketing expertise to distribute Equazen® range in pharmacies and parapharmacies.
Equazen® is a trusted global brand offering science-based nutritional solutions to support brain health and cognitive function. Equazen® products feature a unique combination of essential fatty acids (Omega 3 and Omega 6), proven in over 15 clinical studies to support learning, concentration, and healthy brain development.
Matthew Brabazon, GM of SFI Health™ EMEA commented: “We are excited to offer our science-backed Equazen® solutions to Portuguese consumers, who are becoming more proactive in supporting their cognitive needs. Our entry in Portugal is another step of our development plan to grow in the region by widening our partners network and customer base.”
Mr. Nuno Carvalho, CEO of Eqyon, added: “We believe Equazen® products will make a meaningful impact in our market, thanks to their high-quality ingredients and well-documented benefits. We are proud to bring Equazen® back to Portugal and will work closely with SFI Health™ EMEA to strengthen confidence in natural solutions among healthcare professionals and consumers."
Brain health supplements are one of the fastest growing segments in the global food supplements market: in Europe, between 2023 and 2030, the market is expected to grow at a compound annual rate of 12.5%, driven by increased awareness of cognitive and mental health.
SFI Health™ EMEA and Equazen® are present in several markets, including Spain, United Kingdom, Switzerland, Poland, Czech, Slovak, the Netherlands, the Nordics and the Baltics. The company aims at further widening Equazen® distribution to unlock the potential sales of the brand and make the most of the growing brain health supplements market.
About SFI Health™
SFI Health™ is a global leader in natural healthcare, specialized in the design, development and commercialization of clinically researched products in the areas of microbiome, cognition and wellbeing.
Guided by the belief in the healing potential of natural products, SFI Health™combines a rigorous pharma-based approach with the benefits of naturally sourced solutions.
An extensive network of trusted business partners enables the company, headquartered in Australia, to market its own brands, reaching consumers in over 50 countries. The EMEA SFI Health™ regional office in Lugano, Switzerland, manages commercial operations across Europe, Middle East and Africa.
SFI Health™ is committed to fostering confidence in natural healthcare by sharing state-of-the-art research, technical expertise and comprehensive sales & marketing resources with consumers, healthcare professionals and partners worldwide.
For more information go to sfihealth.com or follow us SFI Health on LinkedIn.
About Eqyon Healthcare Solutions
Eqyon Healthcare Solutions is a customer-focused company dedicated to optimizing healthcare supply chains. By leveraging strategic partnerships and innovative solutions, we help healthcare providers, pharmacies, and institutions improve efficiency, reduce costs, and enhance patient care.
We are committed to addressing the challenges within the healthcare sector through effective, evidence-based solutions. As part of this commitment, we are excited to reintroduce Equazen® to the Portuguese market. Equazen® aligns with our mission to offer natural, scientifically-backed products that promote cognitive health and well-being. In partnership with trusted global brands like Equazen®, we expand access to high-quality, proven solutions that improve lives.
At Eqyon Healthcare Solutions, we aim to be a leading provider of efficient healthcare solutions, continuously transforming challenges into opportunities and ensuring excellence in customer care.
For more information, visit eqyon.eu and follow Eqyon Healthcare Solutions on LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250226258206/en/
Contacts
For more information
SFI Health™ EMEA
Elisabetta Bianchi
e-mail address: elisabetta.bianchi@sfihealth.com
Eqyon
Nuno Carvalho & CEO
e-mail address: nuno.carvalho@eqyon.eu
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Rimini Street and ServiceNow Partner with Apsen Farmacêutica to Deliver a Next-Generation Vision of Enterprise-Wide Workflow Automation7.5.2025 19:55:00 EEST | Press release
Knowledge 2025 —Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support, management and innovation solutions, and the leading third-party support provider for Oracle, SAP and VMware software, today at ServiceNow’s annual customer and partner event, Knowledge 2025, announced that Apsen Farmacêutica, a Brazilian pharmaceutical manufacturer, has partnered with Rimini Street and ServiceNow to implement a next-generation vision of enterprise-wide workflow automation. This new vision will enable autonomy across the company to help respond faster to market changes, reduce information silos and improve operational efficiency. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250507517040/en/ Rimini Street and ServiceNow Partner with Apsen Farmacêutica to Deliver a Next-Generation Vision of Enterprise-Wide Workflow Automation Apsen is prioritizing business needs above technology, leaning into a fl
Results from the VirTus Respiratory Research Ltd Human Rhinovirus Challenge Model Used to Advance Altesa BioSciences’ Lead Medicine into Advanced Clinical Trials7.5.2025 19:07:00 EEST | Press release
VirTus Respiratory Research Ltd, a leading respiratory-focused contract research organisation (CRO), today announced that results from their human rhinovirus challenge model in patients with chronic obstructive pulmonary disease (COPD) provided Altesa BioSciences with compelling evidence to advance their lead drug candidate, vapendavir, into large scale, late-stage clinical trials. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250507489716/en/ Professor Sebastian Johnston https://www.prnewswire.com/news-releases/altesa-biosciences-details-positive-topline-vapendavir-results-from-phase-2-placebo-controlled-rhinovirus-challenge-study-in-copd-patients-302448650.html Rhinovirus infection is the cause of at least half of the acute respiratory deteriorations experienced by the millions of patients with chronic obstructive lung disease. “Before advancing vapendavir into clinical trials testing vapendavir on thousands of patients c
FlightSafety International Announces Major Expansion at Farnborough Airport7.5.2025 18:56:00 EEST | Press release
FlightSafety International (FSI), a global leader in aviation training, is pleased to announce the expansion of its facilities at Farnborough Airport, the home of British aviation and Europe’s leading airport for premium air travel connectivity, highlighting its commitment to enhancing aviation safety and training excellence in Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250506583636/en/ Rendering: arriving at FlightSafety International The new FSI centre is expected to open in the second quarter of 2027. Lease terms have been finalised and the planning application was submitted in January. Construction is scheduled to start in late 2025 and finish by early 2027. FSI has operated a training centre at Farnborough Airport since 2004. The new facilities will boost training capacity by 40-50%, enabling more aviation professionals access to FSI's world-class training programmes. The current facility is 4,680 square met
Verimatrix Positioned as a Leader and Ace Performer in the 2025 SPARK Matrix TM for In-App Protection by QKS Group7.5.2025 18:45:00 EEST | Press release
Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250507970501/en/ Verimatrix positioned as a Leader in the 2025 SPARK Matrix™ for In-App Protection by QKS Group. Verimatrix has been recognized for its comprehensive in-app protection capabilities, earning strong ratings across both Technology Excellence and Customer Impact in the latest SPARK Matrix™. The company has also been named an Ace Performer a recognition given to vendors that demonstrate revenue growth potential, partnership strategy, and customer acquisition—all evaluated over the last one-year period or since the previous SPARK Matrix assessment. The QKS Group SPARK Matrix™ provides competitive analysis & ranking of the leading In-App Protection vendors. For more information about Verimatrix, visit: https://www.verimatrix.com SPARK MatrixTM: In-App Protection, Q1 2025: https://qksgroup.com/market-research/spark-matrix-in-app-protection-q1-2025-8413 V
Amazon to Invest More Than $4 Billion to Launch Infrastructure Region in Chile7.5.2025 16:00:00 EEST | Press release
Amazon (NASDAQ: AMZN) today announced it plans to launch an Amazon Web Services (AWS) infrastructure Region in Chile by the end of 2026. The new AWS South America (Chile) Region will give developers, startups, entrepreneurs, and enterprises, as well as financial services, retail, education, government, and nonprofit organizations, greater choice for running their applications and serving end users from data centers located in Chile. As part of its long-term commitment, Amazon is planning to invest more than $4 billion in Chile to support the construction, connection, operation, and maintenance of its data centers in the country. For more information about AWS Global Infrastructure, visit aws.amazon.com/about-aws/global-infrastructure. “The AWS South America (Chile) Region will help serve the fast-growing demand for cloud services across Latin America and in Chile with secure, reliable, and efficient cloud infrastructure,” said Prasad Kalyanaraman, vice president of Infrastructure Servi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom